There have been 50 recent insider transactions recorded for Aerovate Therapeutics, Inc. (AVTE), including 17 buys and 33 sells. Total insider buying was valued at $15.08M and total insider selling at $3.92M.
Notable insiders with recent activity include Dake Benjamin T, Ra Capital Management, L.p., Eldridge George A. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — AVTE
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2024-08-01 |
Dake Benjamin T |
See Remarks |
Option Exercise (Sell) |
1,507 |
$1.74 |
$2.62K |
- |
| 2024-07-31 |
Dake Benjamin T |
See Remarks |
Option Exercise (Sell) |
10,548 |
$1.74 |
$18.35K |
1,507 |
| 2024-06-17 |
Ra Capital Management, L.p. |
10 Percent Owner |
Informative Buy |
928,110 |
$1.67 |
$1.55M |
7,893,678 |
| 2024-06-14 |
Eldridge George A |
See Remarks |
Informative Sell |
15,000 |
$25.03 |
$375.45K |
5,022 |
| 2024-06-14 |
Verwijs Marinus |
Chief Technical Officer |
Informative Sell |
10,600 |
$25.00 |
$265K |
- |
| 2024-06-13 |
Gillies Hunter |
Chief Medical Officer |
Informative Sell |
6,000 |
$24.50 |
$147K |
5,602 |
| 2024-06-05 |
Santel Donald J |
Director |
RSU Award |
12,500 |
$18.90 |
$236.25K |
12,500 |
| 2024-06-05 |
Ra Capital Management, L.p. |
10 Percent Owner |
RSU Award |
12,500 |
$18.90 |
$236.25K |
12,500 |
| 2024-06-05 |
Iwicki Mark T |
Director |
RSU Award |
12,500 |
$18.90 |
$236.25K |
12,500 |
| 2024-06-05 |
Dorval Allison |
Director |
RSU Award |
12,500 |
$18.90 |
$236.25K |
12,500 |
| 2024-06-05 |
Dable Habib J |
Director |
RSU Award |
12,500 |
$18.90 |
$236.25K |
12,500 |
| 2024-06-05 |
Resnick Joshua |
Director |
RSU Award |
12,500 |
$18.90 |
$236.25K |
12,500 |
| 2024-06-05 |
Katabi Maha |
10 Percent Owner |
RSU Award |
12,500 |
$18.90 |
$236.25K |
12,500 |
| 2024-06-05 |
Grayzel David S. |
Director |
RSU Award |
12,500 |
$18.90 |
$236.25K |
12,500 |
| 2024-05-17 |
Gillies Hunter |
Chief Medical Officer |
Informative Sell |
86 |
$21.86 |
$1.88K |
5,602 |
| 2024-05-16 |
Noyes Timothy P |
Chief Executive Officer |
Informative Sell |
1,293 |
$21.92 |
$28.35K |
- |
| 2024-05-02 |
Verwijs Marinus |
Chief Technical Officer |
Informative Sell |
1,981 |
$21.02 |
$41.63K |
- |
| 2024-05-01 |
Noyes Timothy P |
Chief Executive Officer |
Informative Sell |
965 |
$20.87 |
$20.14K |
- |
| 2024-04-17 |
Gillies Hunter |
Chief Medical Officer |
Option Exercise (Sell) |
3,497 |
$1.74 |
$6.08K |
539 |
| 2024-04-17 |
Dake Benjamin T |
See Remarks |
Informative Sell |
68 |
$23.97 |
$1.63K |
1,291 |
| 2024-04-16 |
Noyes Timothy P |
Chief Executive Officer |
Informative Sell |
5,509 |
$24.94 |
$137.41K |
- |
| 2024-04-10 |
Eldridge George A |
See Remarks |
Informative Sell |
771 |
$27.56 |
$21.25K |
1,960 |
| 2024-04-09 |
Grayzel David S. |
Director |
Informative Sell |
11,882 |
$28.15 |
$334.48K |
14,502 |
| 2024-04-01 |
Noyes Timothy P |
Chief Executive Officer |
Informative Sell |
1,000 |
$31.95 |
$31.95K |
- |
| 2024-04-01 |
Eldridge George A |
See Remarks |
Informative Sell |
12,495 |
$31.23 |
$390.21K |
1,960 |
| 2024-04-01 |
Dake Benjamin T |
See Remarks |
Informative Sell |
3,325 |
$31.97 |
$106.32K |
1,291 |
| 2024-04-01 |
Verwijs Marinus |
Chief Technical Officer |
Informative Sell |
1,504 |
$30.00 |
$45.12K |
- |
| 2024-03-28 |
Gillies Hunter |
Chief Medical Officer |
Informative Sell |
9,000 |
$29.50 |
$265.5K |
3,251 |
| 2024-03-27 |
Dake Benjamin T |
See Remarks |
Informative Sell |
11,068 |
$27.97 |
$309.52K |
1,291 |
| 2024-03-25 |
Dake Benjamin T |
See Remarks |
Informative Sell |
3,432 |
$28.01 |
$96.12K |
1,291 |
| 2024-03-19 |
Verwijs Marinus |
Chief Technical Officer |
Informative Sell |
2,764 |
$26.46 |
$73.12K |
- |
| 2024-03-18 |
Gillies Hunter |
Chief Medical Officer |
Informative Sell |
613 |
$26.40 |
$16.18K |
3,251 |
| 2024-03-18 |
Dake Benjamin T |
See Remarks |
Informative Sell |
7,581 |
$26.48 |
$200.76K |
1,291 |
| 2024-03-13 |
Eldridge George A |
See Remarks |
Informative Sell |
2,016 |
$25.02 |
$50.44K |
1,960 |
| 2024-03-12 |
Eldridge George A |
See Remarks |
Informative Sell |
2,051 |
$25.05 |
$51.37K |
1,960 |
| 2024-03-11 |
Eldridge George A |
See Remarks |
Informative Sell |
10 |
$26.31 |
$263.05 |
1,960 |
| 2024-03-08 |
Eldridge George A |
See Remarks |
Informative Sell |
114 |
$25.00 |
$2.85K |
1,960 |
| 2024-03-07 |
Eldridge George A |
See Remarks |
Informative Sell |
22,386 |
$25.00 |
$559.69K |
1,960 |
| 2024-03-07 |
Gillies Hunter |
Chief Medical Officer |
Informative Sell |
8,975 |
$24.50 |
$219.89K |
3,251 |
| 2024-03-04 |
Dable Habib J |
Director |
RSU Award |
1,531 |
$22.49 |
$34.43K |
1,531 |
| 2024-02-23 |
Gillies Hunter |
Chief Medical Officer |
Option Exercise (Sell) |
511 |
$1.74 |
$889.14 |
3,014 |
| 2024-02-20 |
Gillies Hunter |
Chief Medical Officer |
Informative Sell |
898 |
$20.58 |
$18.48K |
3,251 |
| 2024-02-05 |
Niven Ralph |
Chief Scientific Officer |
Informative Sell |
4,600 |
$17.45 |
$80.25K |
1,609 |
| 2024-01-29 |
Noyes Timothy P |
Chief Executive Officer |
RSU Award |
200,000 |
$18.10 |
$3.62M |
200,000 |
| 2024-01-22 |
Niven Ralph |
Chief Scientific Officer |
RSU Award |
66,586 |
$20.00 |
$1.33M |
66,586 |
| 2024-01-22 |
Eldridge George A |
See Remarks |
RSU Award |
66,586 |
$20.00 |
$1.33M |
66,586 |
| 2024-01-22 |
Gillies Hunter |
Chief Medical Officer |
RSU Award |
66,586 |
$20.00 |
$1.33M |
66,586 |
| 2024-01-22 |
Dake Benjamin T |
See Remarks |
RSU Award |
66,586 |
$20.00 |
$1.33M |
66,586 |
| 2024-01-22 |
Verwijs Marinus |
Chief Technology Officer |
RSU Award |
66,586 |
$20.00 |
$1.33M |
66,586 |
| 2024-01-22 |
Pigot Timothy |
Chief Commercial Officer |
RSU Award |
66,586 |
$20.00 |
$1.33M |
66,586 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
